You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Adjuvant or metastatic setting

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Immunotherapy Among BRAF-Positive Melanoma Patients Treated in

Completed
  • Metastatic Melanoma
  • East Hanover, New Jersey
    Novartis Investigative Site
Nov 11, 2022

Thyroid Trial in Houston (Pembrolizumab)

Recruiting
  • Thyroid
  • Houston, Texas
    M D Anderson Cancer Center
Jul 18, 2022

BCLC A Hepatocellular Carcinoma Non-resectable and Not Amenable for RFA Trial in Bobigny (Durvalumab/Tremelimumab in neoadjuvant

Not yet recruiting
  • BCLC A Hepatocellular Carcinoma Non-resectable and Not Amenable for RFA
  • Durvalumab/Tremelimumab in neoadjuvant and Durvalumab in adjuvant setting
  • Bobigny, France
    Hospitl Avicenne
Sep 13, 2023

LYNPARZA Breast Cancer in Adjuvant Setting Japan Post-Marketing

Not yet recruiting
  • Breast Cancer
    • (no location specified)
    Jan 9, 2023

    Melanoma Trial (Blood samples, Skin biopsy)

    Not yet recruiting
    • Melanoma
    • Blood samples
    • Skin biopsy
    • (no location specified)
    Oct 3, 2022

    Fruquintinib Plus PD-1 in Refractory MSS Metastatic Colorectal

    Completed
    • Colorectal Cancer
    • Fruquintinib combined with anti-PD-1 antibodies
    • ChangSha, Hunan, China
      Hunan Cancer Hospital
    Aug 27, 2023

    Breast Cancer Trial in Shanghai (Pegylated liposomal doxorubicin, Epirubicin, Cyclophosphamid)

    Recruiting
    • Breast Cancer
    • Pegylated liposomal doxorubicin
    • +5 more
    • Shanghai, China
      Shanghai Pudong Hospital
    Dec 11, 2022

    Resistance/Sensitivity and/or Toxicity in Adjuvant Setting for

    Recruiting
    • HER2-positive Breast Cancer
    • Blood sample for genetic analysis
    • Strasbourg, France
      Institut de cancérologie Strasbourg Europe
    Aug 2, 2022

    Stage IIIA Melanoma Receiving Adjuvant Systemic Therapy

    Active, not recruiting
    • Melanoma
      • The Woodlands, Texas
        Local Institution
      Jun 21, 2022

      PRostate Olaparib Real World Evidence Study

      Not yet recruiting
      • Metastatic Castration-resistant Prostate Cancer
        • (no location specified)
        Sep 4, 2023

        Glioma, Glioblastoma, Glioblastoma Multiforme Trial in Houston (VAL-083, Dianhydrogalactitol)

        Active, not recruiting
        • Glioma
        • +4 more
        • VAL-083, Dianhydrogalactitol
        • Houston, Texas
          University of Texas MD Anderson Cancer Center
        Mar 23, 2022

        Chemotherapy Alone Versus Chemotherapy Plus Targeted Therapy as

        Completed
        • Colorectal Cancer Metastatic
        • Targeted agent
        • (no location specified)
        Aug 31, 2023

        QOL of HR-Positive Metastatic BC Treated in First-line Setting:

        Enrolling by invitation
        • Quality of Life
        • Breast Neoplasm Female
        • Quality of Life
        • São Paulo, Brazil
          Hospital Pérola Byington
        Mar 10, 2022

        Breast Tumors, Treatment, Metastatic Breast Cancer Trial (surgical treatment 1, surgical treatment 2, Systemic therapy)

        Not yet recruiting
        • Breast Neoplasms
        • +3 more
        • surgical treatment 1
        • +2 more
        • (no location specified)
        Jul 17, 2022

        Breast Cancer Female, Triple Negative Breast Cancer Trial (quercetin, EGCG, metformin , zinc)

        Not yet recruiting
        • Breast Cancer Female
        • Triple Negative Breast Cancer
        • quercetin, EGCG, metformin , zinc
        • (no location specified)
        Dec 23, 2022

        Tafinlar® + Mekinist® (Dabrafenib + Trametinib)

        Recruiting
        • Malignant Melanoma
        • dabrafenib + trametinib
        • Coimbra, Center, Portugal
        • +5 more
        Jun 9, 2022

        Metastatic Breast Cancer, Tumor, Muscle Tumors Trial in Colorado Springs (Method(s)1 Attribution, Method(s)2 Attribution,)

        Not yet recruiting
        • Metastatic Breast Cancer
        • +3 more
        • Method(s)1 Attribution
        • Method(s)2 Attribution,
        • Colorado Springs, Colorado
          PNAF Medical
        Nov 23, 2023

        Improve Early Detection of Cancer Recurrence in High-Risk

        Recruiting
        • Stage III Melanoma
        • Stage IV Cutaneous Melanoma
          • Cleveland, Ohio
            Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Ca
          Oct 6, 2022

          Breast Cancer Trial in Oslo (Carboplatin, Paclitaxel)

          Active, not recruiting
          • Breast Cancer
          • Oslo, Norway
            Oslo University Hospital
          May 31, 2022

          METAstatic Gastrointestinal Stromal Tumors (METAGIST)

          Recruiting
          • Gastro Intestinal Stromal Tumor
          • oral tyrosine-kinase inhibitors (TKI) of KIT and PDGFR as per recommendations
          • Bordeaux, France
            Institut Bergonié, Comprehensive Cancer Center
          Dec 1, 2022

          Participants Receiving Nivolumab in Adjuvant Setting for

          Active, not recruiting
          • Melanoma
            • Lille, France
              Local Institution
            Mar 17, 2022

            Prostate Cancer Metastatic, Castrate Resistant Prostate Cancer, Metastatic Prostate Cancer Trial in San Antonio (High Intensity

            Recruiting
            • Prostate Cancer Metastatic
            • +3 more
            • High Intensity Interval Training
            • San Antonio, Texas
              UT Health San Antonio
            Feb 17, 2022

            Drug-drug Interactions in Patients Treated With Anticancer

            Recruiting
            • Prostatic Neoplasm
            • data collection
            • Besançon, France
              Centre Hospitalier Universitaire de Besançon
            Nov 9, 2022

            Perihilar Cholangiocarcinoma Trial in Guangzhou (PD-1antibody plus GEMOX)

            Not yet recruiting
            • Perihilar Cholangiocarcinoma
            • PD-1antibody plus GEMOX
            • Guangzhou, Guangdong, China
              Sun Yat-sen Memorial Hospital, Sun Yat-sen University
            Jul 31, 2022

            Colorectal Cancer, Metastatic Cancer Trial in New Brunswick, New York (FOLFOX regimen, dexamethasone, floxuridine)

            Active, not recruiting
            • Colorectal Cancer
            • Metastatic Cancer
            • FOLFOX regimen
            • +7 more
            • New Brunswick, New Jersey
            • +1 more
            Jul 1, 2022